Prosecution Insights
Prosecution Insights
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (25%) |
| Multi-statute (no §101) | 2 (50%) |
| No statute on record | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KRINOS, EMILY LYNN | 1 | — | — |
| KENYON, JOHN S | 1 | 80.2% | +17.5% |
| LEE, JIA-HAI | 1 | 49.7% | +47.9% |
| ESPINOSA, CLAUDIA EDILMA | 1 | 52.9% | +56.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17612038 | USE OF COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING BONE LOSS DISORDERS, COMPRISING CYCLO-HISPRO (CHP) AND PARATHYROID HORMONE | LEE, JIA-HAI | 7d |
| 19107159 | USE OF COMPOSITION CONTAINING ZINC SALT AND CYCLO-HISPRO FOR PREVENTION, ALLEVIATION OR TREATMENT OF RESPIRATORY DISEASE | KRINOS, EMILY LYNN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17406626 | METHOD FOR TREATING INFLAMMATORY BOWEL DISEASES | ESPINOSA, CLAUDIA EDILMA | 18d overdue |
| 17612038 | USE OF COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING BONE LOSS DISORDERS, COMPRISING CYCLO-HISPRO (CHP) AND PARATHYROID HORMONE | LEE, JIA-HAI | 7d |
| 18476630 | PEG-MODIFIED CYCLIC DIPEPTIDES | KENYON, JOHN S | — |
| Art Unit | Apps |
|---|---|
| 1625 | 1 |
| 1658 | 1 |
| 1654 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19107159 | USE OF COMPOSITION CONTAINING ZINC SALT AND CYCLO-HISPRO FOR PREVENTION, ALLEVIATION OR TREATMENT OF RESPIRATORY DISEASE | KRINOS, EMILY LYNN | — | §102§112 | Non-Final OA | — | Pending | Feb 27, 2025 |
| 18476630 | PEG-MODIFIED CYCLIC DIPEPTIDES | KENYON, JOHN S | 1625 | — | Non-Final OA | — | Pending | Sep 28, 2023 |
| 17612038 | USE OF COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING BONE LOSS DISORDERS, COMPRISING CYCLO-HISPRO (CHP) AND PARATHYROID HORMONE | LEE, JIA-HAI | 1658 | §103§112Other | Final Rejection | 7d | Pending | Nov 17, 2021 |
| 17406626 | METHOD FOR TREATING INFLAMMATORY BOWEL DISEASES | ESPINOSA, CLAUDIA EDILMA | 1654 | §103 | Final Rejection | 18d overdue | Pending | Aug 19, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial